The A2bR antagonist ISAM-R56A, can promote the proliferation of T and NK cells, the production of IFN-γ and perforin, and increase the infiltration of tumor-infiltrating lymphocytes into tumor spheres, without altering the expression of adhesion molecules. Here, PRF1 is linked to neoplasm.